Enhanced molecular typing and macrolide and tetracycline-resistance mutations of Treponema pallidum in Barcelona

Future Microbiol. 2019 Sep:14:1099-1108. doi: 10.2217/fmb-2019-0123.

Abstract

Aim: To describe the molecular types of Treponema pallidum and the proportion of macrolide and tetracycline resistance mutations in Barcelona. Materials & methods: Molecular type was determined using the Enhanced-CDC Typing system and antibiotic resistance was determined by sequencing the 23S and 16S rRNA genes. Results: A total of 183 patients were enrolled and 213 specimens (99 ulcers, 114 bloods) were collected. Sixty-two (70.5%) of 88 ulcers and 0 (0%) of bloods T. pallidum-DNA containing samples were fully typed. Up to 21 different strain types were identified (14d/g in 27.4%; 14f/g in 14.5%). Macrolide resistance mutations were present in 95% and tetracycline in 0%. Conclusion: Several different strains co-exist in Barcelona with a high proportion of macrolide resistance and absence of tetracycline resistance.

Keywords: ECDCT methodology; Treponema pallidum; macrolide resistance; molecular typing; syphilis; tetracycline resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • DNA, Bacterial / genetics
  • DNA, Ribosomal / genetics
  • Drug Resistance, Bacterial*
  • Humans
  • Macrolides / pharmacology*
  • Molecular Typing*
  • Mutation
  • Prevalence
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • RNA, Ribosomal, 23S / genetics
  • Sequence Analysis, DNA
  • Spain / epidemiology
  • Syphilis / epidemiology*
  • Syphilis / microbiology
  • Tetracycline / pharmacology*
  • Treponema pallidum / classification*
  • Treponema pallidum / drug effects*
  • Treponema pallidum / genetics
  • Treponema pallidum / isolation & purification

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • DNA, Ribosomal
  • Macrolides
  • RNA, Ribosomal, 16S
  • RNA, Ribosomal, 23S
  • Tetracycline